This award was initiated in 1954 as the Karl Landsteiner Memorial Award and Lectureship, honoring Karl Landsteiner, MD, whose lifetime research laid the foundation for modern blood transfusion therapy. It was renamed the Landsteiner-Alter Award in 2021 to also honor Harvey Alter, MD, longtime AABB member and leader in transfusion medicine, who received the 2020 Nobel Prize in Physiology or Medicine for his research leading to the identification of the Hepatitis C virus. The Landsteiner-Alter Award recognizes a scientist whose original research has resulted in an important contribution to the body of scientific knowledge.
The scientist who receives the award should have an international reputation in transfusion medicine or biotherapies.
To be eligible for this award, candidates:
Recipient is selected by AABB's Board of Directors.
Please send all inquiries about this award to awards@aabb.org.
Jeffrey L Carson, MD, MACP
Paul Hébert, MD, MA, MHSc, FRCPC, FCAHS
Nancy Heddle, MSc, FCSMLS(D)
Ian Roberts, MD
The Landsteiner-Alter Award for 2022 recognizes four outstanding scientists: Jeffrey L. Carson, MD, MACP; Paul C. Hébert, MD, MA, MHSc, FRCPC, FCAHS; Nancy Heddle, MSc, FCSMLS(D); and Ian Roberts, MD, whose careers have advanced novel methodologies and execution of large-scale clinical trials of the efficacy, safety, and complications of transfusion therapies.
December 06, 2023
REGULATORY UPDATE: ‘Ask the FDA and CMS/CLIA 2023’ Annual Meeting Slides Now Available
December 05, 2023
16th Edition of Relationship Testing Standards Takes Effect Jan. 1
December 04, 2023
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
